Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.4400
+0.2250 (104.65%)
At close: Sep 2, 2025, 4:00 PM
0.3650
-0.0750 (-17.05%)
After-hours: Sep 2, 2025, 7:59 PM EDT

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $10.77M in the twelve months ending June 30, 2025, down -48.01% year-over-year. In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth.

Revenue (ttm)
$10.77M
Revenue Growth
-48.01%
P/S Ratio
0.83
Revenue / Employee
$234,065
Employees
46
Market Cap
18.39M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202419.63M4.71M31.59%
Dec 31, 202314.92M5.09M51.71%
Dec 31, 20229.83M--
Dec 31, 2021---
Dec 31, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.